Registered number |
Registered number: | |||||||
Directors' Report | |||||||
The directors present their report and accounts for the year ended |
|||||||
Principal activities | |||||||
During the year to 30th November 2017, the company took its first steps into the marketplace. Our products have generated a great deal of interest and enquiries, which we are working to convert into orders during the forthcoming year. |
|||||||
Directors | |||||||
The following persons served as directors during the year: | |||||||
Small company provisions | |||||||
This report was approved by the board on |
|||||||
Anthony Miles | |||||||
Director | |||||||
Registered number: | |||||||
Balance Sheet | |||||||
as at |
|||||||
Notes | 2017 | 2016 | |||||
£ | £ | ||||||
Fixed assets | |||||||
Tangible assets | 3 | ||||||
Current assets | |||||||
Stocks | - | ||||||
Debtors | 4 | ||||||
Cash at bank and in hand | |||||||
Creditors: amounts falling due within one year | 5 | ( |
( |
||||
Net current liabilities | ( |
( |
|||||
Total assets less current liabilities | ( |
( |
|||||
Creditors: amounts falling due after more than one year | 6 | ( |
( |
||||
Net liabilities | ( |
( |
|||||
Capital and reserves | |||||||
Called up share capital | 2,410 | ||||||
Share premium | 2,448,545 | ||||||
Share option payment reserve | 12 | 3,298 | - | ||||
Profit and loss account | ( |
(3,597,264) | |||||
Shareholders' funds | ( |
( |
|||||
Anthony Miles | |||||||
Director | |||||||
Approved by the board on |
|||||||
Notes to the Accounts | ||||||||
for the year ended |
||||||||
1 | Accounting policies | |||||||
Basis of preparation | ||||||||
Turnover | ||||||||
Tangible fixed assets | ||||||||
Equipment | 25-50% straight line | |||||||
Stocks | ||||||||
Debtors | ||||||||
Creditors | ||||||||
Taxation | ||||||||
Provisions | ||||||||
Foreign currency translation | ||||||||
Leased assets | ||||||||
Pensions | ||||||||
Share-based payments | ||||||||
Equity-settled transactions The cost of equity-settled transactions with employees is measured by reference to the fair value of the equity instruments granted at the date at which they are granted and is recognised as an expense over the vesting period, which ends on the date on which the relevant employees become fully entitled to the award. Fair value is determined by an external valuer using an appropriate pricing model. In valuing equity-settled transactions, no account is taken of any vesting conditions, other than conditions linked to the price of the shares of the company (market conditions) and non vesting conditions. No expense is recognised for awards that do not ultimately vest, except for awards where vesting is conditional upon a market or non vesting condition, which are treated as vesting irrespective of whether or not the market or non vesting condition is satisfied, provided that all other performance conditions are satisfied. At each balance sheet date before vesting, the cumulative expense is calculated, representing the extent to which the vesting period has expired and management's best estimate of the achievement or otherwise of non-market conditions and of the number of equity instruments that will ultimately vest or in the case of an instrument subject to a market condition, be treated as vesting as described above. The movement in cumulative expense since the previous balance sheet date is recognised in the income statement, with a corresponding entry in equity. Where the terms of an equity-settled award are modified or a new award is designated as replacing a cancelled or settled award, the cost based on the original award terms continues to be recognised over the original vesting period. In addition, an expense is recognised over the remainder of the new vesting period for the incremental fair value of any modification, based on the difference between the fair value of the original award and the fair value of the modified award, both as measured on the date of the modification. No reduction is recognised if this difference is negative. Where an equity-settled award is cancelled, it is treated as if it had vested on the date of cancellation, and any cost not yet recognised in the profit and loss account for the award is expensed immediately. Any compensation paid up to the fair value of the award at the cancellation or settlement date is deducted from equity, with any excess over fair value expensed in the profit and loss account. |
||||||||
2 | Employees | 2017 | 2016 | |||||
Number | Number | |||||||
Average number of persons employed by the company | ||||||||
3 | Tangible fixed assets | |||||||
Plant and machinery etc | ||||||||
£ | ||||||||
Cost | ||||||||
At 1 December 2016 | ||||||||
Additions | ||||||||
At 30 November 2017 | ||||||||
Depreciation | ||||||||
At 1 December 2016 | ||||||||
Charge for the year | ||||||||
At 30 November 2017 | ||||||||
Net book value | ||||||||
At 30 November 2017 | ||||||||
At 30 November 2016 | ||||||||
4 | Debtors | 2017 | 2016 | |||||
£ | £ | |||||||
Trade debtors | - | |||||||
Corporation tax - Research and development tax credit receivable | ||||||||
Other taxes and social security | 153,923 | |||||||
Other debtors | ||||||||
5 | Creditors: amounts falling due within one year | 2017 | 2016 | |||||
£ | £ | |||||||
Trade creditors | ||||||||
Taxation and social security costs | ||||||||
Other creditors | ||||||||
6 | Creditors: amounts falling due after one year | 2017 | 2016 | |||||
£ | £ | |||||||
Other creditors | ||||||||
Included in Creditors: amounts falling due after one year are Advances of £1,521,162 (2016: £300,000) received in respect of shares issued in January 2018. | ||||||||
7 | Share-based payments | |||||||
An Enterprise Management Incentive share option scheme was approved in September 2017. Under this scheme the options will vest if the employees who have been granted the options satisfy the working time requirements for the period up to and and including the date of sale of the company. The options will lapse should the employee either leave employment or not meet the defined working time requirements. The contractual life of the options is ten years. The range of exercise prices for options outstanding at the end of the year was £1.55 to £3.33. There are no cash settlement alternatives. During the year the total number of share options granted was 505,700, with a weighted average fair value of the options granted being £0.26 each. The fair value of these equity settled options granted is estimated as at the date of grant based on a third party investment undertaken on an arm's length basis and taking into account performance of the business since that date and the terms and conditions upon which the options are granted. The expense recognised for these equity settled share-based payments during the year to 30 November 2017 is £3,298 (2016: £nil). |
||||||||
8 | Other information | |||||||
DST Innovations Limited is a private company limited by shares and incorporated in England and Wales. Its registered office is: | ||||||||
Ground Floor | ||||||||
6 Bridgend Business Centre | ||||||||
Bennett Street | ||||||||
Bridgend | ||||||||
CF31 3SH |